Middle East and Africa Antacids Market to Grow at a CAGR of 3.0% to reach US$ 659.18 million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Antacids Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Antacids Market – Key Market Dynamics

5.1 Growth Drivers

5.2 Market Opportunities

5.3 Future Trends

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Antacids Market Regional Analysis

6.1 Middle East and Africa Antacids Market Overview

6.2 Middle East and Africa Antacids Market Revenue 2017-2027 (US$ Million)

6.3 Middle East and Africa Antacids Market Forecast Analysis

7. Middle East and Africa Antacids Market Analysis – by Dosage Form

7.1 Tablet

7.1.1 Overview
7.1.2 Tablet: Middle East and Africa Antacids Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Liquid

7.2.1 Overview
7.2.2 Liquid: Middle East and Africa Antacids Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Antacids Market Analysis – by Drug Class

8.1 Proton Pump Inhibitors

8.1.1 Overview
8.1.2 Proton Pump Inhibitors: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

8.2 H2 Antagonist

8.2.1 Overview
8.2.2 H2 Antagonist: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Acid Neutralizers

8.3.1 Overview
8.3.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

9. Middle East and Africa Antacids Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Online Pharmacy

9.3.1 Overview
9.3.2 Acid Neutralizers: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10. Middle East and Africa Antacids Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Antacids Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Middle East and Africa Antacids Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
10.1.1.1.2 South Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
10.1.1.1.3 South Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel

10.1.1.2 Saudi Arabia: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Dosage Form
10.1.1.2.2 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Drug Class
10.1.1.2.3 Saudi Arabia: Middle East and Africa Antacids Market Breakdown, by Distribution Channel

10.1.1.3 UAE: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Antacids Market Breakdown, by Dosage Form
10.1.1.3.2 UAE: Middle East and Africa Antacids Market Breakdown, by Drug Class
10.1.1.3.3 UAE: Middle East and Africa Antacids Market Breakdown, by Distribution Channel

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Antacids Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Dosage Form
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Drug Class
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Antacids Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Antacids Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bayer AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GlaxoSmithKline plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Takeda Pharmaceutical Company Limited

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Sun Pharmaceutical Industries Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Sanofi

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Boehringer Ingelheim International GmbH

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Dr. Reddy's Laboratories

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Pfizer Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Reckitt Benckiser Group Plc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Procter & Gamble

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights